These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 32677612
41. Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity. Garrett D, Montesso F, Fougerolle S, Lopez-Alvarez MR, Birand I, De Bock M, Huang CM, Legrand L, Pronost S, Paillot R. Vet Microbiol; 2017 Nov; 211():150-159. PubMed ID: 29102112 [Abstract] [Full Text] [Related]
42. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2. Dodt J, Costanzo A, Daas A, Hunfeld A, Buchheit KH. Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188 [Abstract] [Full Text] [Related]
43. Collaborative study for the establishment of erythropoietin BRP batch 3. Behr-Gross ME, Daas A, Burns C, Bristow AF. Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137 [Abstract] [Full Text] [Related]
44. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique. Nübling CM, Daas A, Buchheit KH. Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261 [Abstract] [Full Text] [Related]
45. Collaborative study for the calibration of the Ph. Eur. prekallikrein activator in albumin BRP batches 4, 5 and 6. Lackner F, Daas A, Terao E. Pharmeur Bio Sci Notes; 2015 Jan; 2015():1-10. PubMed ID: 26830155 [Abstract] [Full Text] [Related]
46. The potential impact of a single amino-acid substitution on the efficacy of equine influenza vaccines. Yamanaka T, Cullinane A, Gildea S, Bannai H, Nemoto M, Tsujimura K, Kondo T, Matsumura T. Equine Vet J; 2015 Jul; 47(4):456-62. PubMed ID: 24773030 [Abstract] [Full Text] [Related]
47. Collaborative study for the establishment of a European Phamacopoeia Biological reference preparation for Bordetella pertussis mouse antiserum for serological potency testing of acellular pertussis vaccines. Poirier B, Bornstein N, Andre M, Marmonier D, Pares M, Vanhooren G, Rautmann G, Behr-Gross ME, Dobbelaer R, Fuchs F. Biologicals; 2003 Mar; 31(1):25-38. PubMed ID: 12623057 [Abstract] [Full Text] [Related]
48. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed). Stalder J, Costanzo A, Daas A, Rautmann G, Buchheit KH. Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187 [Abstract] [Full Text] [Related]
49. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines. Lucken R, Daas A, Behr-Gross ME. Dev Biol (Basel); 2002 Apr; 111():171-80. PubMed ID: 12678238 [Abstract] [Full Text] [Related]
50. Collaborative study for establishment of a global standard for the potency assay of human anti-D immunoglobulin. Thorpe SJ, Sands D, Fox B, Schäffner G, Yu MW, Behr-Gross ME. Pharmeuropa Bio; 2004 Jan; 2003(2):9-26. PubMed ID: 14960260 [Abstract] [Full Text] [Related]
51. Collaborative study for the establishment of the human immunoglobulin for electrophoresis Ph. Eur. BRP batch 3. Behr-Gross ME, Daas A, Christians S. Pharmeur Bio Sci Notes; 2014 Jan; 2014():71-80. PubMed ID: 25655244 [Abstract] [Full Text] [Related]
52. Collaborative study for the establishment of erythropoietin BRP batch 2. Behr-Gross ME, Daas A, Bristow AF. Pharmeuropa Bio; 2004 Dec; 2004(1):23-33. PubMed ID: 15659283 [Abstract] [Full Text] [Related]
53. Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012. Perglione CO, Gildea S, Rimondi A, Miño S, Vissani A, Carossino M, Cullinane A, Barrandeguy M. Influenza Other Respir Viruses; 2016 Jan; 10(1):37-46. PubMed ID: 26406274 [Abstract] [Full Text] [Related]
54. EDQM biological reference preparation for rabies vaccine (inactivated) for veterinary use. Daas A, Bruckner L, Milne C. Pharmeur Bio Sci Notes; 2015 Jan; 2015():57-72. PubMed ID: 26830159 [Abstract] [Full Text] [Related]
55. Establishment of batch 4 of the Biological Reference Preparation (BRP) for rabies vaccine (inactivated) for veterinary use. Daas A, Milne C. Pharmeuropa Bio; 2004 Dec; 2004(1):17-22. PubMed ID: 15659282 [Abstract] [Full Text] [Related]
56. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed. Sesardic D, Winsnes R, Rigsby P, Tierney R, Gaines-Das R. Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430 [Abstract] [Full Text] [Related]
57. Collaborative study for the establishment of Ph. Eur. Human albumin (molecular size) Biological Reference Preparation batches 1, 2 and 3. Sinitskaya N, Regourd E, Wierer M, Behr-Gross ME, Lièvre V. Pharmeur Bio Sci Notes; 2021 Mar; 2021():184-198. PubMed ID: 34913434 [Abstract] [Full Text] [Related]
58. Establishment of the human coagulation factor VII concentrate European Pharmacopoeia biological reference preparation batch 1. Dodt J, Hunfeld A, Daas A, Buchheit KH. Pharmeuropa Bio; 2006 Nov; 2006(1):15-22. PubMed ID: 17270128 [Abstract] [Full Text] [Related]
59. Isolation and characterization of equine influenza virus (H3N8) from an equine influenza outbreak in Malaysia in 2015. Toh X, Soh ML, Ng MK, Yap SC, Harith N, Fernandez CJ, Huangfu T. Transbound Emerg Dis; 2019 Sep; 66(5):1884-1893. PubMed ID: 31059176 [Abstract] [Full Text] [Related]
60. Collaborative study for the calibration of Ph. Eur. Heparin Low-Molecular-Mass for Assay Biological Reference Preparation batch 11. Terao E, Regourd E. Pharmeur Bio Sci Notes; 2022 Sep; 2022():22-31. PubMed ID: 35481431 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]